Alterations in cytokine levels in cervical carcinoma patients through radiation therapy

Current Science

Volumn 94, Issue 10, 2008, Pages 1292-1296

  Munagala, Radha ^a   Nagarajan, B ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

Carcinoma cervix; Cytokine; HPV; Impaired immunogenic

Indexed keywords

HUMAN PAPILLOMAVIRUS;

EID: 44849144103     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lorincz, A. T. et al., Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obstet. Gynecol., 1992, 79, 328-337.
2. Sharma, A., Rajappa, M., Saxena, A. and Sharma, M., Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix. Int. J. Gynecol. Cancer, 2007, 17, 879-885.
3. Hilders, C. G., Houbiers, J. G., van Ravenswaay, Claasen, H. H., Veldhuizen, R. W. and Fleuren, G. J., Association between HLA-expression and infiltration of immune cells in cervical carcinoma. Lab. Invest., 1993, 69, 651-659.
4. Negus, R. P., Stamp, G. W., Hadley, J. and Balkwill, F. R., Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am. J. Pathol., 1997, 150, 1723-1734.
5. Rotstein, S. et al., Incidence of infectious symptoms after radiation therapy for breast cancer. Long-term effects. Acta Oncol., 1987, 26, 197-201.
6. Radha Munagala and Nagarajan, B., Isolation of RNA from cell scrapings and blood samples from cervical cancer patients. Curr. Sci., 2007, 93, 138-139.
7. Tartour, E. et al., Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: Evidence for enhanced interleukin 6 gene expression in invasive carcinoma. Cancer Res., 1994, 54, 6243-6248.
8. Tilg, H., Dinarello, C. A. and Mier, J. W., IL-6 and APPs: antiinflammatory and immunosuppressive mediators. Immunol. Today, 1997, 18, 428-432.
9. Tang, J. T. et al., Effect of radiotherapy on serum level of interleukin 6 in patients with cervical carcinoma. Anticancer Res., 1996, 16, 2005-2008.
10. El-Sherif, A. M., Seth, R., Tighe, P. J. and Jenkins, D., Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer. J. Pathol., 2001, 195, 179-185.
11. Enzler, T. et al., Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. J. Exp. Med., 2003, 197, 1213-1219.
12. Tartour, E. et al., Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J. Natl. Cancer Inst., 1998, 90, 287-294.
13. Gey, A. et al., Identification and characterisation of a group of cervical carcinoma patients with profound downregulation of intratumoral Type 1 (IFNgamma) and Type 2 (IL-4) cytokine mRNA expression. Eur. J. Cancer, 2003, 39, 595-603.
14. Luo, X., Slater, J. M. and Gridley, D. S., Radiation and endostatin gene therapy in a lung carcinoma model: Pilot data on cells and cytokines that affect angiogenesis and immune status. Technol. Cancer Res. Treat., 2006, 5, 135-146.
15. + tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas, 2004, 28, e26-31.
16. + T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br. J. Cancer, 2006, 94, 275-280.
17. + T lymphocytes as a prognostic factor of survival in endometrial carcinoma. Clin. Cancer Res., 2004, 10, 4450-4456.
18. Steinbrink, K. et al., Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood, 1999, 93, 1634-1642.
19. Bernasconi, S. et al., Effects of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages. Int. J. Cancer, 1995, 60, 300-307.
20. +/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl. Acad. Sci. USA, 2005, 102, 18538-18543.